Diabete

An FDA advisory panel split on Avandia: 12 of 33 members voted to withdraw it, 10 to keep it on the market and seven to add warnings. The FDA's David Graham presented findings that the drug raised heart attack, stroke, heart failure and death risk by 9%, 27%, 25% and 14%.